Yazar "Engin, Yaprak" seçeneğine göre listele
Listeleniyor 1 - 7 / 7
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe The Effect of Aortic Valve Procedure on LVAD Implantation(Wiley-Blackwell, 2012) Engin, Yaprak; Erkul, Sinan; Nalbantgil, Sanem; Zoghi, Mehdi; Engin, Cagatay; Yagdi, Tahir; Ozbaran, MustafaÖğe Heartware HVAD Application In Heart Failure Treatment, Ege University Experience(Wiley-Blackwell, 2012) Erkul, Sinan; Balcioglu, Ozlem; Engin, Yaprak; Daylan, Ahmet; Ozturk, Pelin; Nalbantgil, Sanem; Zoghi, Mehdi; Engin, Cagatay; Askar, Fatma; Yagdi, Tahir; Ozbaran, MustafaÖğe A Lethal Late Complication: Aortoesophageal Fistula after TEVAR(Thieme Medical Publ Inc, 2023) Karaca, Sedat; Yalıç, İslam; Bulut, Barkın; Engin, Yaprak; Poşacıoğlu, HakanThoracic endovascular aortic repair (TEVAR) has been performed in the treatment of thoracic aortic disease since the mid-1990s. Complications associated with TEVAR are increasing rapidly due to its widespread use. One of these complications is late lethal aortoesophageal fistula (AEF). The aim of this study was to describe the diagnosis of AEF in a 64-year-old woman 8 months after TEVAR. The AEF was diagnosed on a computed tomography angiography with oral and intravenous contrast. The patient underwent open surgical repair and died of sepsis 12 days after surgery.Öğe New era of pediatric ventricular assist devices: Let us go to school(Wiley-Blackwell, 2015) Ozbaran, Mustafa; Yagdi, Tahir; Engin, Cagatay; Ulger, Zulal; Ozbaran, Burcu; Kose, Sezen; Kacamak, Duygu; Engin, YaprakAs there is still a shortage of pediatric donor hearts, several techniques have been used to assist pediatric patients to survive until transplantation. VADs provide long-term support and ability of mobilization for children before a suitable heart becomes available. Several devices such as paracorporeal pumps have been used for this purpose, with acceptable morbidity and mortality rates. However, discharge is not possible, as there is no mobile drive unit for these small-sized pumps. The possible negative psychosocial impact of long-term hospitalization, away from home and school, may cause some adjustment problems in the future. In this case series, three pediatric patients that underwent intracorporeal LVAD implantation and returned to school are presented to share clinical experience and also to attract attention to the potential social and psychiatric implications.Öğe New Generation Left Ventricular Assist Device for End Stage Heart Failure Therapy: Ege University Experience(Elsevier Science Inc, 2013) Engin, Yaprak; Yagdi, Tahir; Balcioglu, Ozlem; Engin, Cagatay; Ertugay, Serkan; Nalbantgil, Sanem; Kultayev, Ilyas; Narymbetov, Nurjhan; Zoghi, Mehdi; Ozbaran, MustafaÖğe Risk Factors of Gastrointestinal Bleeding After Continuous Flow Left Ventricular Assist Device(Lippincott Williams & Wilkins, 2018) Balcioglu, Ozlem; Kemal, Hatice S.; Ertugay, Serkan; Ozturk, Pelin; Engin, Yaprak; Nalbantgil, Sanem; Engin, Cagatay; Yagdi, Tahir; Ozbaran, MustafaThis study aimed to compare von Willebrand factor (vWF) levels, ristocetin cofactor levels, platelet counts, aortic valve movements, and right heart failure (RHF) as risk factors of gastrointestinal (GI) bleeding in patients with continuous flow left ventricular assist device (cf-LVAD). In a single centre, 90 patients (mean age 52.0 +/- 10.5 years), of which 59 were male and 31 were female, had cf-LVAD implantation from October 2010 to November 2012. Seventy-six (84.4%) patients had HeartWare (Medtronic, Mounds View, MN) and 14 (15.5%) had Heartmate II (Thoratec, Pleasanton, CA) implanted. vWF level, ristocetin cofactor level, and platelet count were measured before and after implantation to determine the presence of acquired von Willebrand Syndrome; aortic valve movement and postoperative RHF were evaluated to compare the difference in bleeding and nonbleeding patient groups. Fifteen patients (16.6%) suffered GI bleeding after cf-LVAD implantation. A statistically significant decrease was found in vWF and ristocetin cofactor levels from preoperative period to postoperative period in both bleeding and nonbleeding patient groups (p < 0.05). There was no significant difference in bleeding and nonbleeding groups regarding aortic valve movements (p 0.05). Postoperative RHF incidence was significantly high in the bleeding patient group compared with the nonbleeding group (p < 0.05). Therefore, depending on the findings of this study, acquired von Willebrand Syndrome was seen in all cf-LVAD patients, and postoperative RHF was an important risk factor for GI bleeding.Öğe Ventricular Support Systems for End Stage Heart Failure Patients: Which patient, When?(Elsevier Science Inc, 2013) Engin, Yaprak; Engin, Cagatay; Yagdt, Tahir; Ertugay, Serkan; Nalbantgil, Sanem; Zoghi, Mehdi; Balcioglu, Ozlem; Ozturk, Pelin; Ozbaran, Mustafa
